{"id":{"repo_id":"marshall","oai_identifier":"oai:mds.marshall.edu:etd-2840"},"canonical_url":"https://search.ndltd.org/etd/marshall/oai:mds.marshall.edu:etd-2840","repository":{"repo_id":"marshall","name":"Marshall University","base_url":"https://mds.marshall.edu/do/oai/"},"display":{"title":"Effects of disulfiram on the metabolome of MRSA","abstract":"Disulfiram, known as Antabuse®, is an oral drug for the treatment of alcohol dependence. Previous studies have indicated that disulfiram (DSF) exhibits antibacterial effects, particularly against Gram-positive bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). Our study delves into the antibacterial mechanism of DSF in MRSA through High-Pressure Liquid Chromatography (HPLC) metabolomics, investigating the underlying mechanism of DSF effects on thiamine and amino acid metabolism. Thiamine pyrophosphate (TPP) plays a crucial role as a cofactor for critical enzymes such as transketolase, pyruvate dehydrogenase, and 2-oxoglutarate dehydrogenase. These enzymes are integral to the carbohydrate metabolism process within bacterial cells. TPP also contributes to coenzyme A (CoA) biosynthesis, identified as a prospective drug target for DSF in MRSA. Recent research highlighted DSF's role in lowering intracellular CoA levels in MRSA, and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways helped to uncover enriched genes related to the biosynthesis of TPP. Our transcriptome data further illuminated different amino acid metabolism shifts within DSF-treated MRSA. In-depth HPLC investigations utilized various methods to gauge TPP and amino acid levels in DSF-treated MRSA. These HPLC results effectively validated our hypothesis, confirming DSF's influence on increasing cellular levels of TPP and amino acids like glutamate, glutamine, arginine, glycine, β-alanine, and lysine. Notably, our study also revealed diminished cellular levels of aspartate, valine, phenylalanine, and threonine. Our comprehensive study offers further insight on why DSF treatment alters TPP and select amino acid levels. These findings add to our understanding of DSF's antibacterial mechanism in MRSA.","abstract_html":"Disulfiram, known as Antabuse®, is an oral drug for the treatment of alcohol dependence. Previous studies have indicated that disulfiram (DSF) exhibits antibacterial effects, particularly against Gram-positive bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). Our study delves into the antibacterial mechanism of DSF in MRSA through High-Pressure Liquid Chromatography (HPLC) metabolomics, investigating the underlying mechanism of DSF effects on thiamine and amino acid metabolism. Thiamine pyrophosphate (TPP) plays a crucial role as a cofactor for critical enzymes such as transketolase, pyruvate dehydrogenase, and 2-oxoglutarate dehydrogenase. These enzymes are integral to the carbohydrate metabolism process within bacterial cells. TPP also contributes to coenzyme A (CoA) biosynthesis, identified as a prospective drug target for DSF in MRSA. Recent research highlighted DSF&#x27;s role in lowering intracellular CoA levels in MRSA, and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways helped to uncover enriched genes related to the biosynthesis of TPP. Our transcriptome data further illuminated different amino acid metabolism shifts within DSF-treated MRSA. In-depth HPLC investigations utilized various methods to gauge TPP and amino acid levels in DSF-treated MRSA. These HPLC results effectively validated our hypothesis, confirming DSF&#x27;s influence on increasing cellular levels of TPP and amino acids like glutamate, glutamine, arginine, glycine, β-alanine, and lysine. Notably, our study also revealed diminished cellular levels of aspartate, valine, phenylalanine, and threonine. Our comprehensive study offers further insight on why DSF treatment alters TPP and select amino acid levels. These findings add to our understanding of DSF&#x27;s antibacterial mechanism in MRSA.","abstract_has_math":false,"creators":["Naidu, Surya Teja"],"institution":null,"degree_name":"Pharmaceutical Sciences","degree_level":"Thesis","degree_discipline":"School of Pharmacy","degree_department":null,"school":null,"contributors":["Dr. Timothy E Long, Committee Chairperson","Dr. Hasan Koc","Dr. Michael Hambuchen"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-21T19:58:10Z","subjects":["Chemicals and Drugs","Medical Pharmacology","Medical Sciences","Medicinal and Pharmaceutical Chemistry","Medicine and Health Sciences","Pharmaceutical Preparations","Pharmacy and Pharmaceutical Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://mds.marshall.edu/etd/1835","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://mds.marshall.edu/etd/1835","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://mds.marshall.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Amds.marshall.edu%3Aetd-2840","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Dr. Timothy E Long, Committee Chairperson","Dr. Hasan Koc","Dr. Michael Hambuchen"]},{"key":"dc:creator","label":"Author","values":["Naidu, Surya Teja"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2024-01-05T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2023-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["School of Pharmacy"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Pharmaceutical Sciences"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Chemicals and Drugs","Medical Pharmacology","Medical Sciences","Medicinal and Pharmaceutical Chemistry","Medicine and Health Sciences","Pharmaceutical Preparations","Pharmacy and Pharmaceutical Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://mds.marshall.edu/etd/1835"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Disulfiram, known as Antabuse®, is an oral drug for the treatment of alcohol dependence. Previous studies have indicated that disulfiram (DSF) exhibits antibacterial effects, particularly against Gram-positive bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). Our study delves into the antibacterial mechanism of DSF in MRSA through High-Pressure Liquid Chromatography (HPLC) metabolomics, investigating the underlying mechanism of DSF effects on thiamine and amino acid metabolism. Thiamine pyrophosphate (TPP) plays a crucial role as a cofactor for critical enzymes such as transketolase, pyruvate dehydrogenase, and 2-oxoglutarate dehydrogenase. These enzymes are integral to the carbohydrate metabolism process within bacterial cells. TPP also contributes to coenzyme A (CoA) biosynthesis, identified as a prospective drug target for DSF in MRSA. Recent research highlighted DSF's role in lowering intracellular CoA levels in MRSA, and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways helped to uncover enriched genes related to the biosynthesis of TPP. Our transcriptome data further illuminated different amino acid metabolism shifts within DSF-treated MRSA. In-depth HPLC investigations utilized various methods to gauge TPP and amino acid levels in DSF-treated MRSA. These HPLC results effectively validated our hypothesis, confirming DSF's influence on increasing cellular levels of TPP and amino acids like glutamate, glutamine, arginine, glycine, β-alanine, and lysine. Notably, our study also revealed diminished cellular levels of aspartate, valine, phenylalanine, and threonine. Our comprehensive study offers further insight on why DSF treatment alters TPP and select amino acid levels. These findings add to our understanding of DSF's antibacterial mechanism in MRSA."]},{"key":"dc:title","label":"Title","values":["Effects of disulfiram on the metabolome of MRSA"]}]}],"canonical_facts":{"dc:contributor":["Dr. Timothy E Long, Committee Chairperson","Dr. Hasan Koc","Dr. Michael Hambuchen"],"dc:creator":["Naidu, Surya Teja"],"dc:date.available":["2024-01-05T08:00:00Z"],"dc:date.created":["2023-01-01T08:00:00Z"],"dc:description.abstract":["Disulfiram, known as Antabuse®, is an oral drug for the treatment of alcohol dependence. Previous studies have indicated that disulfiram (DSF) exhibits antibacterial effects, particularly against Gram-positive bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). Our study delves into the antibacterial mechanism of DSF in MRSA through High-Pressure Liquid Chromatography (HPLC) metabolomics, investigating the underlying mechanism of DSF effects on thiamine and amino acid metabolism. Thiamine pyrophosphate (TPP) plays a crucial role as a cofactor for critical enzymes such as transketolase, pyruvate dehydrogenase, and 2-oxoglutarate dehydrogenase. These enzymes are integral to the carbohydrate metabolism process within bacterial cells. TPP also contributes to coenzyme A (CoA) biosynthesis, identified as a prospective drug target for DSF in MRSA. Recent research highlighted DSF's role in lowering intracellular CoA levels in MRSA, and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways helped to uncover enriched genes related to the biosynthesis of TPP. Our transcriptome data further illuminated different amino acid metabolism shifts within DSF-treated MRSA. In-depth HPLC investigations utilized various methods to gauge TPP and amino acid levels in DSF-treated MRSA. These HPLC results effectively validated our hypothesis, confirming DSF's influence on increasing cellular levels of TPP and amino acids like glutamate, glutamine, arginine, glycine, β-alanine, and lysine. Notably, our study also revealed diminished cellular levels of aspartate, valine, phenylalanine, and threonine. Our comprehensive study offers further insight on why DSF treatment alters TPP and select amino acid levels. These findings add to our understanding of DSF's antibacterial mechanism in MRSA."],"dc:identifier":["https://mds.marshall.edu/etd/1835"],"dc:subject":["Chemicals and Drugs","Medical Pharmacology","Medical Sciences","Medicinal and Pharmaceutical Chemistry","Medicine and Health Sciences","Pharmaceutical Preparations","Pharmacy and Pharmaceutical Sciences"],"dc:title":["Effects of disulfiram on the metabolome of MRSA"],"thesis:degree_discipline":["School of Pharmacy"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Pharmaceutical Sciences"]},"updated_at":"2026-11-21T19:58:10Z"}